Minimal Residual Disease and Its Impact on the Clinical Management of Patients With Leukemia.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 4, p. 144
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2020 AND VI 34 AND IP 4
Results: 9
1
2
HPV and the Immune System in Head and Neck Cancers: Therapeutic Considerations.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 4, p. 139
- By:
- Publication type:
- Article
3
FDA Approves Nivolumab Plus Ipilimumab for the Treatment of Advanced HCC.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 4, p. 137
- By:
- Publication type:
- Article
4
The Changing Landscape of Targeted Breast Cancer Therapies.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 4, p. 132
- By:
- Publication type:
- Article
5
Advancing the Field of Breast Cancer Care: A "sea change" in treatment.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 4, p. 130
- By:
- Publication type:
- Article
6
Progression of Castration-Resistant Prostate Cancer After Docetaxel and Androgen Receptor-Targeting Agent.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 4, p. 125, doi. 10.46883/onc.2020.3404.0125
- By:
- Publication type:
- Article
7
Recurrent Small Cell Carcinoma of the Lung With Cutaneous Metastasis in Breast.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 4, p. 120
- By:
- Publication type:
- Article
8
Oncology in the Time of COVID-19.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 4, p. 119
- By:
- Publication type:
- Article
9
The Rapid Evolution of Breast Cancer Care.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 4, p. 118
- By:
- Publication type:
- Article